S&P 500   3,327.63 (+0.00%)
DOW   27,219.32 (+0.07%)
QQQ   271.80 (+0.28%)
AAPL   447.24 (+1.59%)
MSFT   213.18 (+0.11%)
FB   262.12 (+5.22%)
GOOGL   1,491.35 (+0.83%)
AMZN   3,198.18 (-0.21%)
NVDA   450.28 (-0.26%)
CGC   18.15 (-5.52%)
BABA   261.55 (-1.27%)
TSLA   1,489.88 (+0.33%)
MU   48.87 (-4.27%)
GE   6.32 (-1.25%)
AMD   86.16 (+1.00%)
T   29.82 (-0.10%)
F   6.94 (-0.29%)
ACB   10.25 (-4.30%)
GILD   68.72 (-0.41%)
NFLX   503.61 (+0.30%)
DIS   129.11 (+1.18%)
BAC   25.41 (+0.08%)
BA   172.87 (-0.81%)
S&P 500   3,327.63 (+0.00%)
DOW   27,219.32 (+0.07%)
QQQ   271.80 (+0.28%)
AAPL   447.24 (+1.59%)
MSFT   213.18 (+0.11%)
FB   262.12 (+5.22%)
GOOGL   1,491.35 (+0.83%)
AMZN   3,198.18 (-0.21%)
NVDA   450.28 (-0.26%)
CGC   18.15 (-5.52%)
BABA   261.55 (-1.27%)
TSLA   1,489.88 (+0.33%)
MU   48.87 (-4.27%)
GE   6.32 (-1.25%)
AMD   86.16 (+1.00%)
T   29.82 (-0.10%)
F   6.94 (-0.29%)
ACB   10.25 (-4.30%)
GILD   68.72 (-0.41%)
NFLX   503.61 (+0.30%)
DIS   129.11 (+1.18%)
BAC   25.41 (+0.08%)
BA   172.87 (-0.81%)
S&P 500   3,327.63 (+0.00%)
DOW   27,219.32 (+0.07%)
QQQ   271.80 (+0.28%)
AAPL   447.24 (+1.59%)
MSFT   213.18 (+0.11%)
FB   262.12 (+5.22%)
GOOGL   1,491.35 (+0.83%)
AMZN   3,198.18 (-0.21%)
NVDA   450.28 (-0.26%)
CGC   18.15 (-5.52%)
BABA   261.55 (-1.27%)
TSLA   1,489.88 (+0.33%)
MU   48.87 (-4.27%)
GE   6.32 (-1.25%)
AMD   86.16 (+1.00%)
T   29.82 (-0.10%)
F   6.94 (-0.29%)
ACB   10.25 (-4.30%)
GILD   68.72 (-0.41%)
NFLX   503.61 (+0.30%)
DIS   129.11 (+1.18%)
BAC   25.41 (+0.08%)
BA   172.87 (-0.81%)
S&P 500   3,327.63 (+0.00%)
DOW   27,219.32 (+0.07%)
QQQ   271.80 (+0.28%)
AAPL   447.24 (+1.59%)
MSFT   213.18 (+0.11%)
FB   262.12 (+5.22%)
GOOGL   1,491.35 (+0.83%)
AMZN   3,198.18 (-0.21%)
NVDA   450.28 (-0.26%)
CGC   18.15 (-5.52%)
BABA   261.55 (-1.27%)
TSLA   1,489.88 (+0.33%)
MU   48.87 (-4.27%)
GE   6.32 (-1.25%)
AMD   86.16 (+1.00%)
T   29.82 (-0.10%)
F   6.94 (-0.29%)
ACB   10.25 (-4.30%)
GILD   68.72 (-0.41%)
NFLX   503.61 (+0.30%)
DIS   129.11 (+1.18%)
BAC   25.41 (+0.08%)
BA   172.87 (-0.81%)
Log in

NASDAQ:ADILAdial Pharmaceuticals Price Target & Analyst Ratings

$1.86
+0.19 (+11.38 %)
(As of 08/6/2020 12:27 PM ET)
Add
Compare
Today's Range
$1.74
Now: $1.86
$2.45
50-Day Range
$1.33
MA: $1.46
$1.89
52-Week Range
$1.00
Now: $1.86
$3.17
Volume212,446 shs
Average Volume911,296 shs
Market Capitalization$25.02 million
P/E RatioN/A
Dividend YieldN/A
Beta0.98

Analyst Ratings

Adial Pharmaceuticals (NASDAQ:ADIL) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: N/AN/ABuyBuy
Consensus Rating Score: N/AN/A3.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/A$5.00$5.00
Price Target Upside: N/AN/A134.74% upside134.74% upside

Adial Pharmaceuticals (NASDAQ:ADIL) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Adial Pharmaceuticals (NASDAQ:ADIL) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/7/2019Maxim GroupSet Price TargetBuy$5.00Medium
4/12/2019Dawson JamesReiterated RatingBuyMedium
(Data available from 8/6/2018 forward)
This page was last updated on 8/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.